Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Marcadia Biotech Inc.

Division of Roche

Latest From Marcadia Biotech Inc.

Beta/Islet Cell Regeneration Leads Diabetes Deal-Making This Decade

A review of deal-making in the diabetes space since 2010 finds deals around technology to regenerate pancreatic beta cells and/or islet cells as the hottest mechanism of action. Thirteen deals in this area out-number the combined deals involving the DPP-4, SGLT-2 and GLP-1 mechanisms during that period.

BioPharmaceutical Deals

CMEA 8 Is Kaput, But A Would-Be Partner Moves On With Wellspring

Just this past January, CMEA was touting its upcoming eighth fund and two new partners with a string of early-stage biotech successes on their resumes. The fund is now dissolved, but one would-be CMEA 8 partner has moved on with a new asset-centric incubator.

United States Strategy

Financings Of The Fortnight: Life Science Venture Funding Not Necessarily On The Decline

Plus news on recent financings by Foundation Medicine, Ultragenyx, Labrys Biologics, Solstice Biologics and Sarepta Therapeutics.

Business Strategies

Daiichi's Handsome Buyout Price Validates Plexxikon's Business Model

In an era in which biotechs struggle to get financing and Big Pharma is hungry for new drugs but typically favors deals that delay rewards, Plexxikon Inc. appears to have been dealt a top R&D hand and played its cards exceedingly well. Its strategy has culminated in one of the priciest private buyouts in recent history, its $805 million up-front acquisition by Japan’s Daiichi Sankyo Co. Ltd.
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • PhySci Pharmaceuticals
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Roche
  • Senior Management
  • Fritz French, CEO
    Kristin Sherman, CFO
    Richard DiMarchi, PhD, CSO
    Kent Hawryluk, VP, Bus. Dev.
    Jas Gidda, PhD, VP, R&D
  • Contact Info
  • Marcadia Biotech Inc.
    Phone: (317) 566-2266
    11711 N. Meridian St., Ste. 300
    Carmel, IN 46032